Showing 98,181 - 98,200 results of 102,958 for search '(( 2 wt decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.40s Refine Results
  1. 98181

    Table_1_Retrospective investigation of the origin and epidemiology of the dengue outbreak in Yunnan, China from 2017 to 2018.DOCX by Liang Cao (135383)

    Published 2023
    “…<p>Since 2013, a dengue epidemic has broken out in Yunnan, China and neighboring countries. …”
  2. 98182

    Supplementary Material for: Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable He... by Takada H. (11871941)

    Published 2022
    “…Cases without decreased blood flow in TIC analysis (<i>n</i> = 10) had more cases with PD compared with cases with decreased blood flow (60 vs. 0%, <i>p</i> = 0.001). …”
  3. 98183

    Table_1_Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.docx by Johanna Matull (18767917)

    Published 2024
    “…GNAQ and GNA11 mutations were common in uveal melanomas, while MAP-Kinase mutations were frequent in non-uveal melanomas with NF1, BRAF V600 and NRAS Q61 mutations occurring in decreasing frequency, consistent with a strong UV association. …”
  4. 98184

    Data_Sheet_1_Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung... by Xia Luo (169127)

    Published 2022
    “…When compared with lorlatinib and alectinib, ensartinib was associated with a lower QALY and decreased total costs; the ICERs for lorlatinib and alectinib were $934,101/ QALY and $164,888/ QALY, respectively.…”
  5. 98185
  6. 98186
  7. 98187
  8. 98188
  9. 98189
  10. 98190
  11. 98191
  12. 98192
  13. 98193
  14. 98194
  15. 98195
  16. 98196
  17. 98197
  18. 98198
  19. 98199
  20. 98200